Careful volume assessment appears to be the critical factor in achieving clinical trial dose of sacubitril/valsartan in the community.
26 May 2019 (08:30 - 18:00)
Organised by:
Abstract
Slides
About the speaker
University Hospital Sant Joan de Reus, Reus (Spain)
55 More presentations in this session
Access the full session
The Event
Heart Failure 2019
26 May 2019
08:30 CET
You may be interested in
Congress Presentation
